Clinical Trials Browser

Phase 1/2 × Terminated × obatoclax × Clear all

NCT00724841 2016-07-22

A Phase I/II Study of GMX1777 in Combination With Temozolomide for the Treatment of Metastatic Melanoma

Phase 1/2 Terminated

Melanoma

NCT00719901 2015-01-12

Obatoclax and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 1/2 Terminated

11 enrolled 9 charts

Multiple Myeloma